Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine)
General Physician
MBBS, MCPS (Family Medicine)
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Diabetologist
M.B.B.S, M.R.C.P (Ireland), M.R.C.P (Endocrinology and Diabetes - UK)
Endocrinologist
M.B.B.S, FCPS-Medicine (Aga Khan University), Fellowship in Diabetes and Endocrinology (Aga Khan university), FCPS Endocrinology
Endocrinologist
M.B.B.S, FCPS-Medicine (Aga Khan University), Fellowship in Diabetes and Endocrinology (Aga Khan university), FCPS Endocrinology
Internal Medicine Specialist
FCPS (Medicine), M.B.B.S.
Diabetologist
M.B.B.S., PGD Diabetes, MPhil Endocrine Physiology, Masters Family Medicine, Masters Family Medicine
Diabetologist
M.B.B.S., PGD Diabetes, MPhil Endocrine Physiology, Masters Family Medicine, Masters Family Medicine
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures